Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast CancerMelanie Royce, Christy Osgood, Flora Mulkey, et al.
JAMA Oncology|March 23, 2018
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical TrialMelanie Royce, Thomas Bachelot, Cristian Villanueva, et al.
Cytokine|December 31, 2003
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapyLajos Pusztai, Tito R Mendoza, James M Reuben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project RenewalSundeep Agrawal, Clara Lee, William F Pierce, et al.
Future Oncology (London, England)|December 17, 2009
Prognostic value of nodal ratios in node-positive breast cancer: a compiled updateVincent Vinh-Hung, Nam P Nguyen, Gábor Cserni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in ReviewShaily Arora, Preeti Narayan, Christy L Osgood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2021
U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in ReviewShaily Arora, Preeti Narayan, Gwynn Ison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2025
FDA Approval Summary: Datopotamab deruxtecan-dlnk for treatment of patients with unresectable or metastatic, HR-positive, HER2-negative breast cancerMelanie Royce, Mirat Shah, Lijun Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Pageof 4